Rituximab Can Induce Remission in a Patient with Ankylosing Spondylitis Who Failed Anti-TNF-α Agent.
about
Effect of Interferon-γ Polymorphisms on Ankylosing Spondylitis: A Case-Control StudySystematic review of the role of rituximab in treatment of antineutrophil cytoplasmic autoantibody-associated vasculitis, hepatitis C virus-related cryoglobulinemic vasculitis, Henoch-Schönlein purpura, ankylosing spondylitis, and Raynaud's phenomen
P2860
Rituximab Can Induce Remission in a Patient with Ankylosing Spondylitis Who Failed Anti-TNF-α Agent.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Rituximab Can Induce Remission ...... s Who Failed Anti-TNF-α Agent.
@en
type
label
Rituximab Can Induce Remission ...... s Who Failed Anti-TNF-α Agent.
@en
prefLabel
Rituximab Can Induce Remission ...... s Who Failed Anti-TNF-α Agent.
@en
P2093
P2860
P356
P1476
Rituximab Can Induce Remission ...... s Who Failed Anti-TNF-α Agent.
@en
P2093
Ahd Majdali
Fahmi AlDhaheri
Hani Almoallim
Nahed Janoudi
Talal Almteri
P2860
P304
P356
10.12659/AJCR.900563
P577
2017-02-09T00:00:00Z